GASTON-DREYFUS REMI received a stock award from BIONIK LABORATORIES CORP.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 12/13/2021ACC: 0001104659-21-149126
Director10% Owner
Since Jul 2018
+61.26K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
61.26K acquired
Non-Derivative Transactions1
Common Stock, par value $0.001 per share
Indirect
Shares
+61.26K
Price / share
—
Trade value
—
% of position
4.3%
3/29/2021
1.42M→1.48M
Total
Net shares
+61.26K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock, par value $0.001 per share Indirect | 3/29/2021 | A · Award | +61.26K | — | — | 4.3% | 1.42M | 1.48M |
| Total | +61.26K | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock, par value $0.001 per share
DirectShares owned61.26K
Total
61.26K direct61.26K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock, par value $0.001 per share | 61.26K | Direct |
| Total | 61.26K | 61.26K direct |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported